How effective is Paxlovid in treating mild COVID-19?
Taskforce Director, Tari Turner, together with Primary Chronic Care Co-Chairs Nicole Allard and Mark Morgan and Disease-Modifying Treatments & Chemoprophylaxis Panel Members Amanda Gwee and Jason Roberts, explain the effectiveness, risk factors and accessibility of Paxlovid for people with mild COVID-19 in The Conversation.